CD38 and neoplasm: We observed that as compared to PBMC (peripheral blood mononuclear cells), CD8+ T cells at the tumor site exhibited dramatic increase in the expression of PD1 (Figure 1C), CD38 (Figure 1D), and Tim3 (Figure 1E), while Lag3 expression (Figure 1F) was comparable.